The endocannabinoid system regulates synaptic transmission in nucleus accumbens by increasing DAGL-α expression following short-term morphine withdrawal

British Journal of Pharmacology

Volumn 173, Issue 7, 2016, Pages 1143-1153

  Wang, Xing Qin ^a   Ma, Jie ^a   Cui, Wei ^b   Yuan, Wei Xin ^a   Zhu, Gang ^a   Yang, Qian ^a   Heng, Li Jun ^a   Gao, Guo Dong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCANNABINOID; LIPOPROTEIN LIPASE; MORPHINE;

ANIMAL; CONDITIONING; CORPUS STRIATUM; METABOLISM; MORPHINE ADDICTION; NERVE CELL INHIBITION; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION; WITHDRAWAL SYNDROME;

ANIMALS; CONDITIONING (PSYCHOLOGY); CORPUS STRIATUM; ENDOCANNABINOIDS; LIPOPROTEIN LIPASE; MORPHINE; MORPHINE DEPENDENCE; NEURAL INHIBITION; NUCLEUS ACCUMBENS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME; SYNAPTIC TRANSMISSION;

EID: 84961773009     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12969     Document Type: Article

References (53)

1. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The concise guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol 170: 1459-1581.
2. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The concise guide to PHARMACOLOGY 2013/14: Ligand-gated ion channels. Br J Pharmacol 170: 1582-1606.
3. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013c). The concise guide to PHARMACOLOGY 2013/14: enzymes. Br J Pharmacol 170: 1797-1867.
4. Alvarez-Jaimes L, Polis I, Parsons LH, (2008). Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB1 antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala. Neuropsychopharmacology 33: 2483-2493.
5. Azizi P, Haghparast A, Hassanpour-Ezatti M, (2009). Effects of CB1 receptor antagonist within the nucleus accumbens on the acquisition and expression of morphine-induced conditioned place preference in morphine-sensitized rats. Behav Brain Res 197: 119-124.
6. Bennett BD, Bolam JP, (1994). Synaptic input and output of parvalbumin-immunoreactive neurons in the neostriatum of the rat. Neuroscience 62: 707-719.
7. Carai MA, Colombo G, Gessa GL, Yalamanchili R, Basavarajappa BS, Hungund BL, (2006). Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice. Br J Pharmacol 148: 1043-1050.
8. Centonze D, Rossi S, De Chiara V, Prosperetti C, Battista N, Bernardi G, et al. (2007). Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors. Eur J Neurosci 25: 1631-1640.
9. Chevaleyre V, Takahashi KA, Castillo PE, (2006). Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29: 37-76.
10. Cossu G, Ledent C, Fattore L, Imperato A, Böhme GA, Parmentier M, et al. (2001). Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res 118: 61-65.
11. De Vries TJ, Homberg JR, Binnekade R, Raaso H, Schoffelmeer AN, (2003). Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology (Berl) 168: 164-169.
12. Di Chiara G, Tanda G, Bassareo V, Pontieri F, Acquas E, Fenu S, et al. (1999). Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. Ann N Y Acad Sci 877: 461-485.
13. Fattore L, Deiana S, Spano SM, Cossu G, Fadda P, Scherma M, et al. (2005). Endocannabinoid system and opioid addiction: behavioural aspects. Pharmacol Biochem Behav 81: 343-359.
14. Fattore L, Spano M, Melis V, Fadda P, Fratta W, (2011). Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats. Br J Pharmacol 163: 1550-1562.
15. Gao Y, Vasilyev DV, Goncalves MB, Howell FV, Hobbs C, Reisenberg M, et al. (2010). Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci 30: 2017-2024.
16. Gonzalez S, Fernandez-Ruiz J, Sparpaglione V, Parolaro D, Ramos JA, (2002). Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels. Drug Alcohol Depend 66: 77-84.
17. Haghparast A, Shamsizadeh A, Samandari R, Omranifard A, Vaziri A, Razavi Y, (2014). Cannabinoid receptors in the basolateral amygdala are involved in the potentiation of morphine rewarding properties in the acquisition, but not expression of conditioned place preference in rats. Brain Res 1565: 28-36.
18. Hashimotodani Y, Ohno-Shosaku T, Kano M, (2007). Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus. J Neurosci 27: 1211-1219.
19. Hillard CJ, Weinlander KM, Stuhr KL, (2012). Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience 204: 207-229.
20. Hohmann AG, Herkenham M, (2000). Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. Synapse 37: 71-80.
21. Hyman SE, Malenka RC, Nestler EJ, (2006). Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29: 565-598.
22. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: Reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
23. Koos T, Tepper JM, (1999). Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat Neurosci 2: 467-472.
24. Kreitzer AC, Regehr WG, (2001). Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29: 717-727.
25. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, et al. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283: 401-404.
26. Lee JH, Kim HY, Jang EY, Choi SH, Han CH, Lee BH, et al. (2011). Effect of acupuncture on naloxone-precipitated withdrawal syndrome in morphine-experienced rats: the mediation of GABA receptors. Neurosci Lett 504: 301-305.
27. Liang J, Lindemeyer AK, Suryanarayanan A, Meyer EM, Marty VN, Ahmad SO, et al. (2014). Plasticity of GABA(A) receptor-mediated neurotransmission in the nucleus accumbens of alcohol-dependent rats. J Neurophysiol 112: 39-50.
28. Luscher C, (2013). Drug-evoked synaptic plasticity causing addictive behavior. J Neurosci 33: 17641-17646.
29. Manzanares J, Corchero J, Romero J, Fernandez-Ruiz JJ, Ramos JA, Fuentes JA, (1999). Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 20: 287-294.
30. Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O, (2000). Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur J Neurosci 12: 4038-4046.
31. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
32. Meredith GE, (1999). The synaptic framework for chemical signaling in nucleus accumbens. Ann N Y Acad Sci 877: 140-156.
33. Narushima M, Uchigashima M, Hashimoto K, Watanabe M, Kano M, (2006). Depolarization-induced suppression of inhibition mediated by endocannabinoids at synapses from fast-spiking interneurons to medium spiny neurons in the striatum. Eur J Neurosci 24: 2246-2252.
34. Ohno-Shosaku T, Maejima T, Kano M, (2001). Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29: 729-738.
35. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl. Acids Res. 42 (Database Issue): D1098-D1106.
36. Randall CK, Kraemer PJ, Bardo MT, (1998). Morphine-induced conditioned place preference in preweanling and adult rats. Pharmacol Biochem Behav 60: 217-222.
37. Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Minarro J, (2003). Reinstatement of morphine-induced conditioned place preference in mice by priming injections. Neural Plast 10: 279-290.
38. Robison AJ, Vialou V, Mazei-Robison M, Feng J, Kourrich S, Collins M, et al. (2013). Behavioral and structural responses to chronic cocaine require a feedforward loop involving ΔFosB and calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell. J Neurosci 33: 4295-4307.
39. Robledo P, Berrendero F, Ozaita A, Maldonado R, (2008). Advances in the field of cannabinoid-opioid cross-talk. Addict Biol 13: 213-224.
40. Rubino T, Massi P, Vigano D, Fuzio D, Parolaro D, (2000). Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome. Life Sci 66: 2213-2219.
41. Sidhpura N, Parsons LH, (2011). Endocannabinoid-mediated synaptic plasticity and addiction-related behavior. Neuropharmacology 61: 1070-1087.
42. Starowicz K, Di Marzo V, (2013). Non-psychotropic analgesic drugs from the endocannabinoid system: 'magic bullet' or 'multiple-target' strategies? Eur J Pharmacol 716: 41-53.
43. Uchigashima M, Narushima M, Fukaya M, Katona I, Kano M, Watanabe M, (2007). Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J Neurosci 27: 3663-3676.
44. Vigano D, Grazia Cascio M, Rubino T, Fezza F, Vaccani A, Di Marzo V, et al. (2003). Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain. Neuropsychopharmacology 28: 1160-1167.
45. Vigano D, Valenti M, Cascio MG, Di Marzo V, Parolaro D, Rubino T, (2004). Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine. Eur J Neurosci 20: 1849-1857.
46. Wills KL, Vemuri K, Kalmar A, Lee A, Limebeer CL, Makriyannis A, et al. (2014). CB antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats. Psychopharmacology (Berl) 231: 4291-4300.
47. Wilson RI, Nicoll RA, (2001). Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410: 588-592.
48. Xi ZX, Ramamoorthy S, Shen H, Lake R, Samuvel DJ, Kalivas PW, (2003). GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine. J Neurosci 23: 3498-3505.
49. Yamaguchi T, Hagiwara Y, Tanaka H, Sugiura T, Waku K, Shoyama Y, et al. (2001). Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice. Brain Res 909: 121-126.
50. Yoon SS, Kim H, Choi KH, Lee BH, Lee YK, Lim SC, et al. (2010). Acupuncture suppresses morphine self-administration through the GABA receptors. Brain Res Bull 81: 625-630.
51. Yuan WX, Heng LJ, Ma J, Wang XQ, Qu LJ, Duan L, et al. (2013). Increased expression of cannabinoid receptor 1 in the nucleus accumbens core in a rat model with morphine withdrawal. Brain Res 1531: 102-112.
52. Zarrindast MR, Mousa-Ahmadi E, (1999). Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice. Eur J Pharmacol 381: 129-133.
53. Zhou FM, Wilson CJ, Dani JA, (2002). Cholinergic interneuron characteristics and nicotinic properties in the striatum. J Neurobiol 53: 590-605.